Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
| ▸ | PPARA | Q07869 | 1/20 | 0.34 |
| ▸ | BRAF | P15056 | 3/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.34 |
| ▸ | RAF1 | P04049 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4409883 | 0.87 | MAPK14 (0.36) | MAPTCYP1A2CYP3A4CYP2C19MAPK14 | |
| SCHEMBL5603582 | 0.87 | MAPK14 (0.37) | MAPTCYP1A2CYP3A4CYP2C19MAPK14 | |
| SCHEMBL4565792 | 0.85 | MAPT (0.41) | MAPTCYP1A2CYP3A4CYP2C19MAPK14 | |
| SCHEMBL4411132 | 0.85 | BRAF (0.38) | MAPTCYP1A2CYP3A4CYP2C19MAPK14 | |
| SCHEMBL4413425 | 0.83 | GAA (0.39) | MAPTCYP1A2CYP3A4CYP2C19SMN1; SMN2 | |
| SCHEMBL4410129 | 0.83 | MEN1 (0.44) | MAPTCYP1A2CYP3A4CYP2C19MAPK14 | |
| SCHEMBL4412714 | 0.82 | MAPT (0.35) | MAPTCYP1A2CYP3A4CYP2C19MAPK14 | |
| SCHEMBL4410261 | 0.82 | NPC1 (0.39) | MAPTCYP1A2CYP3A4CYP2C19MAPK14 | |
| SCHEMBL4411278 | 0.82 | MAPT (0.37) | MAPTCYP1A2CYP3A4CYP2C19KDM4E | |
| SCHEMBL4420133 | 0.81 | RAB9A (0.48) | CYP1A2KDM4ESMN1; SMN2BRAFRAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2035005-A2 | THERAPY USING CYTOKINE INHIBITORS | Kemia, INC. (US) | 2009-03-18 | — | — | EP | disclosed |
| WO-2007146712-A2 | THERAPY USING CYTOKINE INHIBITORS | KEMIA, INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007075896-A2 | HETEROCYCLIC CYTOKINE INHIBITORS | KEMIA, INC. (US) | 2007-07-05 | — | — | WO | disclosed |
| WO-2007075896-A2 | HETEROCYCLIC CYTOKINE INHIBITORS | KEMIA, INC. (US) | 2007-07-05 | — | — | WO | disclosed |